GNI Group Ltd. (2160) Earnings Releases & Disclosures
Upcoming
- 2026-11-13 Earnings Announcement
| Date | Type | Title | Files |
|---|---|---|---|
| 2026-11-06 | Earnings Release | Notice Regarding Third Quarter 2026 Financial Results and Update on the F351 NDA Review by Our Subsidiary Gyre Therapeutics | |
| 2026-10-07 | — | From the Growth Market to TOPIX: GNI Group Newly Selected in the First Periodic Review Following TOPIX Reform | |
| 2026-09-03 | — | Promotion of Proprietary Brand Business in the Medtech Segment | |
| 2026-08-24 | — | Notice Regarding Change in Major Shareholder | |
| 2026-08-18 | Presentation Materials | Q2 FY2026 Financial Results Corporate Presentation | |
| 2026-08-14 | Earnings Release | Consolidated Financial Results for Q2 FY2026 (IFRS) | |
| 2026-08-14 | Forecast Revision | Notice Regarding Revision to Full-Year Consolidated Financial Forecast |
TDnet keeps only 31 days; this site accumulates daily and cannot backfill earlier disclosures.